Here, disruption of the PHD2/VHL pathway and the role of HIF2α was investigated in a pseudohypoxia model of endothelial dysfunction simulating aspects of PAH and PH pathobiology. The gene discussed is EGLN1; the disease is pulmonary arterial hypertension.